Long Term

Related by string. Longer term * long : Long Term Capital / term : Long Term Care * Long Term Debt . Long Term Evolution LTE . Long Term Evolution . hedge fund Long Term . Long Term Projections . Long Term Incentive Plan . LTE Long Term . 4G Long Term . Long Term Recovery . Long Term Ecological . Long Term Borrowings . Long Term Unemployed . Long Term Viability . Long Term Liabilities *

Related by context. All words. (Click for frequent words.) 64 Longer Term 64 Short Term 60 Near Term 59 Paying Dividends 59 Remains Unchanged 59 Bodes Well 58 Paying Off 58 Success Depends 58 Re Affirms 58 Showing Signs 58 Concerns Remain 57 Deteriorate 57 Remains Positive 57 Phasing Out 57 Lupus Drug 57 Drops Sharply 57 Prolongs 57 Cost Efficiencies 57 Wins Approval 57 Reforms Needed 57 Sees Modest 57 Report Examines 57 Sustained Growth 57 Boost Economy 57 Short Lived 57 Viable Option 57 Debt Repayment 57 Remains Committed 57 Sees Positive 57 Sees Continued 57 Progresses 57 Lag Behind 57 Viable Alternative 56 Funds Announce 56 Rate Increases 56 Risks Remain 56 Remains Uncertain 56 Outlook Improves 56 Chart Presentation 56 Extend Rally 56 Reduce Expenses 56 Seeks Approval 56 Rising Interest Rates 56 Clock Ticking 56 Report Suggests 56 Could Derail 56 Remain Unchanged 56 Boosts Profit 56 Few Surprises 56 Significantly Reduce 56 Reaffirms Commitment 56 Reaches Tentative 56 Help Improve 56 Experts Advise 56 Underpin 56 Hits Lowest Level 56 Steadies 56 Spells Out 56 Yen Climbs 56 Steps Toward 56 Outstrips 56 Looks Promising 56 Much Needed 56 Ramping Up 56 Sharply Higher 56 First Step Toward 56 Enhance Shareholder Value 56 Poses Risk 56 Looks Toward 56 Weighed Down 56 Debt Offerings 56 Remains Strong 55 Higher Interest Rates 55 Diminishes 55 Emerging Mkts 55 Nears Deal 55 Weak Economy 55 Resolve Dispute Over 55 Lung Cancer Drug 55 Cautiously Optimistic 55 Emphasizes Need 55 Restates 55 Improve Profitability 55 Pros Cons 55 Rates Remain 55 Can Withstand 55 Considers Options 55 Shoring Up 55 Final Stages 55 Slows Down 55 Rating Affirmed 55 Be Studied 55 Be Explored 55 Japanese Stocks Climb 55 Significant Increase 55 Improve Quality 55 Uncertainty Remains 55 Reduce Risk 55 Obtains Financing 55 Shows Promise 55 Holding Pattern 55 Largely Unchanged 55 Pressure Builds 55 Remains Confident 55 Could Hinder 55 Revised Downward 55 Wide Ranging 55 Fall Sharply 55 Retools 55 Sees Steady 55 Costs Rise 55 Sharpen Focus 55 Urges Stronger 55 Rating Raised 55 Resolve Dispute 55 Pays Off 55 Gets Nod 55 Being Studied 55 Outweighs 55 Hits Speed Bump 55 Could Harm 55 Seeks Buyer 55 Sees Possible 55 Lays Out 55 Puts Off 55 Range Bound 55 Buying Opportunity 55 Clinical Remission 55 Cautious Optimism 55 Worries Persist 55 Steep Rise 55 Dollar Weakness 55 Be Evaluated 55 Slower Than Expected 55 Discontinues 55 Remains Weak 55 Remain Intact 55 Revised Upward 55 Offers Incentives 55 Challenges Remain 55 Still Unclear 55 Rates Decline 55 Overestimated 55 Faces Difficult 55 Reduces Risk 55 Gap Widens 55 Sees Gradual 55 Highlights Importance 55 Worsens 55 Lower Than Expected 55 Winding Down 55 Refinance Debt 55 Gaining Traction 55 More Than Doubled 55 Gain Traction 55 Could Hurt 55 Significantly Improved 55 Near Collapse 55 Forges Ahead 55 Outlines Plans 55 Cast Doubt 54 Forecast Raised 54 Provides Updated 54 Gaining Steam 54 Data Suggest 54 Pays Dividends 54 Shifts Gears 54 Repay Debt 54 Could Weaken 54 Osteoarthritis Pain 54 Opportunities Exist 54 Maintains Strong 54 Interest Rates Unchanged 54 Study Examines 54 Steady Ahead 54 Can Predict 54 Losing Steam 54 Reap Rewards 54 Down Sharply 54 Remains Stable 54 Awaits Approval 54 Slight Improvement 54 Move Toward 54 Shortens 54 Portend 54 Raises Doubts 54 Remain Positive 54 Tame Inflation 54 Reverses Course 54 Ticks Higher 54 Remain Stable 54 Provides Guidance 54 Missed Opportunity 54 Low Versus Yen 54 Restructure Debt 54 Deadline Nears 54 Must Adapt 54 Report Outlines 54 Pension Obligations 54 Could Imperil 54 Low Interest Rates 54 Feels Pinch 54 Report Assesses 54 Up Sharply 54 Submits Application 54 Scaling Back 54 Far Exceeds 54 Leveling Off 54 Lowest Level 54 CREDIT MARKETS 54 Epilepsy Drug 54 Positive Outcome 54 Erase Gains 54 Deadline Arrives 54 Pare Gains 54 Deficit Narrows 54 Bumps Up 54 Announces Discontinuation 54 Study Analyzes 54 Outlook Revised 54 Sign Pact 54 Traders Await 54 Statin Drugs 54 Profitable Growth 54 Shows Signs 54 Rises Slightly 54 Important Milestone 54 Reaps Rewards 54 Nears End 54 Update# 54 Moves Towards 54 Negotiations Continue 54 Pave Way 54 Safer Than 54 Weaker Than 54 Could Backfire 54 Focus Shifts 54 Little Changed 54 Long Term Viability 54 What Constitutes 54 Terminate Merger 54 Up Slightly 54 Erase Losses 54 Remains Unclear 54 Rating Lowered 54 Bigger Role 54 Talks Underway 54 Pushes Ahead 54 Gives Boost 54 Pose Serious 54 Momentum Continues 54 Holds Steady 54 Pulls Down 54 Looks Ahead 54 Next Decade 54 Must Rethink 54 Have Doubled 54 Tentative Deal Reached 54 Finalises 54 Stimulus Measures 54 Sustained Reduction 54 Faces Hurdles 54 Significantly Expand 54 RealMoney Radio Recap 54 Downward Pressure 54 Spur Growth 54 Fifth Consecutive 54 Long Term Survival 54 Moody Downgrade 54 Stays Strong 54 Interest Rates Rise 54 Weaken 54 Stabilizes 54 Proves Successful 54 Lowest Levels 54 Scaled Back 54 Optimistic About 54 Study Reinforces 54 Yuan Revaluation 54 Reconfirms 54 Loses Momentum 54 Future Uncertain 54 Muni Bond 54 Hits Roadblock 54 Lowest Ever 54 Record Highs 54 Drops Below 54 Outlook Remains 53 Interest Rate Increases 53 Hits Highest Level 53 Down Slightly 53 Lagging Behind 53 Fitch Teleconference 53 Guidelines Issued 53 Economists React 53 Vastly Different 53 Accelerator Pedals 53 Recession Worries 53 Support LTS 53 Poses Risks 53 Yields Rise 53 Slightly Lower 53 Double Digit 53 Dollar Steady 53 Economy Improves 53 Board Authorizes 53 Hits Milestone 53 Help Ease 53 Rises Sharply 53 Remains Bullish 53 Significantly Increases 53 Risk Appetite 53 Will Worsen 53 Data Disappoints 53 Keeps Falling 53 Diversifies 53 Weak Dollar 53 Prospects Dim 53 Execs Say 53 Beefs Up 53 Could Prove Costly 53 Confirms Commitment 53 Yield Advantage 53 Overly Optimistic 53 Quantifies 53 Extend Gains 53 Debt Refinancing 53 Apfn 53 Positive Results 53 Could Mean 53 Dollar Steadies 53 Slightly Higher 53 Tap Into 53 Edges Lower 53 Nearing Deal 53 Can Be Avoided 53 Buying Spree 53 Off Lows 53 Restate Results 53 Study Explores 53 Woes Worsen 53 Has Slowed 53 Unveils Ambitious 53 Actively Seeking 53 Continues Commitment 53 Challenges Loom 53 Long Awaited 53 Closely Linked 53 Investors Await 53 Rheumatoid Arthritis Patients 53 Doubts Remain 53 Poniard Pharmaceuticals Announces 53 Raises Concerns 53 Negatively Impact 53 Remain Strong 53 Cautiously Optimistic About 53 Update7 53 Biggest Problem 53 Experts Weigh 53 Restrains 53 Gets Approval 53 Less Than Half 53 Unions Agree 53 Divulges 53 Legislation Introduced 53 Fewer Side Effects 53 Make Comeback 53 Clears Path 53 Proposed Changes 53 Spell Trouble 53 Lowers Forecast 53 Minyan Mailbag 53 Haggle Over 53 Puts Pressure 53 Expand Scope 53 Feasible 53 Faces Dilemma 53 Extends Losses 53 Clears Hurdle 53 Jointly Explore 53 Tread Carefully 53 Step Closer 53 Cash Infusion 53 Stocks Wobble 53 Invest Heavily 53 Holds Firm 53 Speculation Mounts 53 Step Toward 53 Questions Loom 53 Broadens Its 53 Drop Sharply 53 Formalizes 53 Reaffirms 53 Puts Focus 53 Gains Traction 53 Sees Slight 53 Defers 53 Gaining Momentum 53 Remain Flat 53 Growing Rapidly 53 Deadline Looms 53 Percent Jump 53 Prolongs Life 53 Uncertain Future 53 Makes Strides 53 Agreement Reached 53 Remains Fragile 53 Drift Lower 53 Smaller Than Expected 53 Worsen 53 Fine Tunes 53 Liquidity Position 53 Beefed Up 53 Slower Growth 53 Will Remain 53 Seventh Consecutive 53 Upward Trend 53 Repay Bailout 53 Play Crucial Role 53 Prioritizes 53 Housing Slump 53 Aggressive Expansion 53 Moody Downgrades 53 Biggest Gain 53 Reaches Highest 53 Progress Toward 53 Critical Juncture 53 Woes Remain 53 Outperforms 53 Hip Surgery 53 Fluctuate 53 Sees Strong 53 Announcement Regarding 53 Helps Lift 53 Ratings Lowered 53 Leaning Toward 53 Concerns Persist 53 Helps Relieve 53 Slowing Economy 53 Demonstrates Commitment 53 Disconnect Between 53 Market Awaits 53 Pumps Up 53 Nears Decision 53 Submits Revised 53 Cuts Loom 53 Their Respective 53 Inches Towards 53 Tax Rebates 53 Greenspan Warns 53 Loses Ground 53 Pays Dividend 53 Remains Stuck 53 Econ Crisis 53 Poll Shows Support 53 Growth Spurt 53 Deteriorates 53 Rate Climbs 53 Renewed Optimism 53 Continues Slide 53 Futures Decline 53 Propping Up 53 Poses Challenges 53 Partisan Divide 53 WebTech Wireless Announces 53 Offing 53 Be Delayed 53 Critical Role 53 Suffers Setback 53 Biggest Threat 53 Achieves Significant 53 Interest Rate Hikes 53 Subprime Woes 53 Talks Stall 53 More Efficiently 53 Edges Closer 53 Smallpox Vaccine 53 Biggest Drop 53 Exec Pay 53 Greatly Improved 53 RealMoney Radio Mailbag 53 Sees Robust 53 Report Identifies 53 Greenhouse Gas Reductions 53 Robust Growth 53 Inches Closer 53 To Repay TARP 53 Submits Proposal 53 Closely Monitoring 53 Rapidly Expanding 53 Falls Sharply 53 Steer Clear Of 53 Biggest Obstacle 53 Rates Rise 53 Negative Consequences 53 Yields Surge 53 GBP#.# Billion [002] 53 Faces Challenges 53 Tight Lipped 53 Improve Energy Efficiency 53 Showed Significant 53 Under Scrutiny 53 Modest Gains 53 Hepatitis C Treatment 53 Causes Concern 53 Underscore Need 53 Unsecured Debt 52 Outlook Brightens 52 Could Save Lives 52 Remain Subdued 52 Saves Money 52 Hit Highest Level 52 Well Positioned 52 Highest Priority 52 Reap Benefits 52 Questions Remain About 52 Upside Potential 52 Edges Toward 52 Share Repurchases 52 Too Costly 52 Faster Than Expected 52 Be Discussed 52 Remains Intact 52 Face Hurdles 52 Treasuries Decline 52 Seek Compromise 52 Sets Deadline 52 Study Casts Doubt 52 Persists 52 Holding Steady 52 Extends Gains 52 Cost Cutting 52 Foreseen 52 Futures Tumble 52 Negatively Affect 52 Stresses Need 52 Widely Used 52 Decision Delayed 52 Medium Term 52 Obese Patients 52 Remain Steady 52 Various Types 52 Rethinks 52 Bailout Funds 52 Curtails 52 Passes Milestone 52 Downward Trend 52 Longest Losing Streak 52 Uncertainty Surrounds 52 Improves Survival 52 Improves Outcomes 52 Step Towards 52 Put Brakes 52 Key Role 52 Demand Grows 52 Lowers Earnings 52 Significant Improvements 52 Higher Than Expected 52 Stocks Soar 52 Helps Ensure 52 Has Passed 52 Could Hamper 52 Takes Backseat 52 Helps Improve 52 Make Headway 52 Narrow Range 52 Downsizes 52 Has Doubled 52 Achieve Goals 52 Raises Full 52 Mostly Higher 52 Significant Improvement 52 Growth Slowed 52 Ratings Unchanged 52 Radically Change 52 Underlie 52 Mixed Ahead 52 Issues Surrounding 52 Market Turmoil 52 Funding Shortfall 52 Bonds Little Changed 52 Fate Hangs 52 Rate Rises 52 Faces Scrutiny 52 Inflation Targeting 52 Minimize Risk 52 Lowers Outlook 52 Prices Surge 52 Expert Predicts 52 Mostly Unchanged 52 Economic Viability 52 Remain Weak 52 Gives Cautious 52 Makes Significant 52 Heading Towards 52 Panel Advises 52 Contract Dispute 52 Modest Growth 52 Momentum Builds 52 Rating Upgraded 52 Study Recommends 52 Dividend Payers 52 Helps Boost 52 Outshines 52 Rise Dramatically 52 Bigger Problem 52 Sell Itself 52 Slight Gains 52 Slightly Weaker 52 Reduce Costs 52 Debt Issuance 52 Euro Denominated 52 Lose Steam 52 Interest Rate Hike 52 Cost Effectiveness 52 Accelerates 52 Weaker Than Expected 52 Hits Record 52 Little Changed Before 52 MARKET TALK NZ 52 Lowest Rate 52 Could Worsen 52 Ceases 52 Outweigh 52 Declines Slightly 52 Study Predicts 52 Better Than Expected 52 Significantly Strengthens 52 Bleak Outlook 52 Dramatically Reduce 52 Lays Out Plan 52 Recommends Changes 52 Structural Changes 52 Improves Slightly 52 Shows Efficacy 52 Sees Stronger 52 Extend Declines 52 Bails Out 52 Multiple Myeloma Patients 52 Liquidates 52 Less Costly 52 Seen Boosting 52 Concerns Arise 52 Mean Reversion 52 Paves Way 52 Key Milestones 52 Pressure Mounts 52 Heading Toward 52 Effort Needed 52 Stock Repurchases 52 Growing Importance 52 Be Tested 52 Gathers Pace 52 Finalize Deal 52 Cheaper Than 52 Swap Deal 52 Pessimistic About 52 Outlines 52 Gathers Momentum 52 Gathers Steam 52 Injectable Drug 52 Study Compares 52 Could Trigger 52 Mixed Reaction 52 Sweeping Changes 52 Boost Profits 52 Affirms Commitment 52 EUR1 Billion 52 Trend Continues 52 Interest Rate Increase 52 Longer Than 52 Monetary Easing 52 Deadline Extended 52 Stimulate Economy 52 Signs Multiyear 52 Contemplates 52 Moves Ahead 52 Consolidates 52 Remains Steady 52 Furthers 52 Dramatically Reduced 52 #.#Bln 52 Yen Weakens 52 Upside Surprise 52 Renegotiates 52 Pose Risk 52 Talks Collapse 52 Bogs Down 52 Expresses Disappointment 52 Stagnates 52 Bankers Bonuses 52 Stave Off 52 Meets Expectations 52 Stepped Up 52 Correlation Between 52 Drug Coated Stents 52 Settle Lawsuits 52 Remains Elusive 52 MBS AFTERNOON 52 Lease Renewal 52 Firms Seek 52 Assess Impact 52 Shares Climb 52 Gloomy Outlook 52 Significantly Improves 52 Stocks Plummet 52 Reduce Debt 52 Fend Off 52 Outlines Plan 52 Yen Retreats 52 Build Momentum 52 Premiums Rise 52 Retiree Benefits 52 Debt Buyback 52 Largest Publicly Traded 52 Econ Data 52 Significant Reduction 52 Econ Recovery 52 Growing Trend 52 Accomplishes 52 Demonstrates Potential 52 Headed Towards 52 Versus Dollar 52 Osteoporosis Drug 52 Share Buybacks 52 Could Threaten 52 Renews Commitment 52 Restructures 52 Gloomy Forecast 52 Growing Faster Than 52 Expresses Confidence 52 Realigns 52 Seen Slowing 52 Drastically Cut 52 Remains Optimistic 52 Ink Pact 52 Clock Ticks 52 Are Little Changed 52 Compelling Case 52 Significantly Reduces 52 Minimal Impact 52 Comprehensive Approach 52 Study Indicates 52 Repositions 52 Stocks Fall Sharply 52 Quadrupled 52 Could Generate 52 Dollar Recovers 52 Provides Updates 52 Extend Deadline 52 Economy Recovers 52 Maximize Value 52 Cuts Costs 52 Reduces Debt 52 Rise Slightly 52 Gives Glimpse 52 Peanut Allergies 52 Tough Task 52 Boosts Share Buyback 52 Backs Off 52 Recoups 52 Deadline Passes 52 Forecast Predicts 52 Tightens Belt 52 Riskier Than 52 Wider Than Expected 52 Raising Debt Ceiling 52 Study Proves 52 Antipsychotic Drugs 52 Hormonal Therapy 52 Move Closer 52 Multi Billion Dollar 52 Envoy Sees 52 Shortage Threatens 52 Cut Greenhouse Gases 52 Presses Ahead 52 Yen Gains 52 Longest Rally 52 Growth Slowing 52 Ominous Signs 52 Underperforms 52 Made Easier 52 Adopt #b# 1 52 Heading Into 52 Shows Modest 52 Remain Committed 52 Help Small Businesses 52 Gains Steam 52 GoldCore Update 52 Multibillion Dollar 52 Junk Status 52 Nears Completion 52 Rates Steady 52 Fending Off 52 Rheumatoid Arthritis Drug 52 Cholesterol Drugs 52 Update9 52 FindProfit.com Provides Investment 52 Unique Challenges 52 Stake Sale 52 Futures Climb 52 Reaches Accord 52 Shares Plummet 52 Trim Losses 52 Adversely Affects 52 Nears Approval 52 Remain Above 52 CNY# Billion 52 Seeks Delay 52 Revamps 52 Raises Concern 52 Smooth Transition 52 Cuts Dividend 52 Progressing Well 52 Budget Deficits 52 Prospers 52 Weekly Gain 52 Positively Impact 51 Deal Reached 51 Double Digit Growth 51 Hits Snag 51 Report Sheds Light 51 Outlook Uncertain 51 Sees Opportunity 51 Remain Volatile 51 Negative Impact 51 Reiterates Commitment 51 Cultivates 51 Face Tougher 51 Data Indicate 51 Stocks Little Changed 51 Faces Uphill Battle 51 Weighs Options 51 Eighth Consecutive 51 Fourth Consecutive 51 Antidepressant Treatment 51 Stands Ready 51 Weigh Options 51 Portfolio Diversification 51 Refines 51 Adverse Effects 51 Highest Level Since 51 Helps Ease 51 Deadline Approaches 51 Margin Expansion 51 Remain Divided 51 Holds Gains 51 Exec Sees 51 Announces Revised 51 Avert Crisis 51 Challenges Ahead 51 Reaction Mixed 51 Jointly Develop 51 Differs From 51 Commence Immediately 51 Sharply Lower 51 Appears Safe 51 Higher Yielding 51 Asset Swap 51 Sells Remaining 51 Significantly Improve 51 Suggests Ways 51 Positive Territory 51 Fiscal Stimulus 51 Future Unclear 51 Opts Out 51 Worse Than Expected 51 Contract Renewal 51 Exceed Previous 51 Biggest Decline 51 Concerns Raised 51 Stocks Surge 51 Ink Deal 51 Terminates 51 Ratings Affirmed 51 Soars Above 51 Remain Competitive 51 Sell Off 51 Futures Rise 51 Repay TARP 51 Unravels 51 Keeps Pressure 51 Loan Guarantees 51 Strongly Supports 51 Edges Up 51 Raise Concerns 51 Demonstrates Improved 51 Drops Slightly 51 Negotiators Agree 51 Reaping Benefits 51 Summarizes 51 Debate Rages 51 Session Lows 51 Non Negotiable 51 Undercuts 51 Not Ruled Out 51 Lie Ahead 51 Temporarily Suspends 51 Pare Losses 51 Evidence Suggests 51 Inching Toward 51 Pose Problems 51 Inch Higher 51 Risk Averse 51 Actively Managed ETFs 51 Investors Await Fed 51 Nudges Up 51 Devalues 51 Weaker Yen 51 Stimulus Dollars 51 Shortchanges 51 Boosts Survival 51 Long Term Commitment 51 Amends Credit 51 Vs Yen 51 Multimillion Dollar 51 Remain Hopeful 51 Larger Than Expected 51 Gets Thumbs Down 51 Sees Progress 51 Balanced Approach 51 Urgently Needed 51 Expands Scope 51 Treating Depression 51 Casts Doubt 51 Increased Scrutiny 51 Tightening Concerns 51 Rises Less Than 51 Markets Await 51 Makes Headway 51 Vary Widely 51 Dollar Slides 51 Diverge 51 Lay Offs 51 Virtually Unchanged 51 Exceeds 51 Recommends Approval 51 Different Approach 51 Fare Poorly 51 Psychological Effects 51 Hit Snag 51 Dipping Into 51 Mortgage Modifications 51 Could Ruin 51 Pushes Back 51 Increases Risk 51 Negotiates 51 Decides Against 51 Different Paths 51 Dollar Advances 51 Vetterkind Cattle 51 Could Affect 51 Inches Up 51 Stages Comeback 51 Million Pounds Sterling 51 Contract Extension 51 Talks Continue 51 Extend Losses 51 Accepts Offer 51 Secures Long Term 51 Grants Awarded 51 Reaffirm Commitment 51 Moving Forward 51 Slight Decline 51 Settle Suit Over 51 Bright Spots 51 Stronger Than Expected 51 Has Been Made 51 Inflationary Pressures 51 Flexes Muscles 51 Concerns Linger 51 Dollar Gains 51 Nears Record 51 Prostate Surgery 51 Cognitive Function 51 Dollar Extends Gains 51 Proposed Legislation 51 Anounces 51 Approves Revised 51 Prostate Cancer Vaccine 51 Stiff Competition 51 Continue Slide 51 Sustain Growth 51 Report Analyzes 51 Shingles Vaccine 51 Dollar Weakens 51 Prostate Cancer Treatment 51 Draws Skepticism 51 Default Risk 51 IrelandRESEARCH AND MARKETS 51 Outlines Strategy 51 Propose Changes 51 Pay Hikes 51 Flu Vaccine Shortage 51 Announces Organizational Changes 51 Near Record Lows 51 Study Shows Benefits 51 Pose Challenges 51 Subprime Crisis

Back to home page